This study showed that lipocalin-2 levels are elevated in patients with PCOS compared with controls (p < 0.001) and that lipocalin-2 may prove to be a useful marker of IR in patients with PCOS [40]. This evidence concerns the gene LCN2 and polycystic ovary syndrome.